| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway
|
Nguyen, Kim-Son H.
|
|
2009
|
10 |
Supplement 1 |
p. 281-289
9 p.
|
article
|
| 2 |
Cancer Treatments: Can We Find Treasures at the Bottom of the Sea?
|
Provencio, Mariano
|
|
2009
|
10 |
Supplement 1 |
p. 295-300
6 p.
|
article
|
| 3 |
Cisplatin plus Gemcitabine as Adjuvant Chemotherapy for Radically Resected Non–Small-Cell Lung Cancer: A Pilot Study
|
Tibaldi, Carmelo
|
|
2009
|
10 |
Supplement 1 |
p. 53-57
5 p.
|
article
|
| 4 |
Contralateral Cervicomediastinal Lymph Node Metastases from Clinically Occult Adenocarcinoma of the Lung
|
Hoshikawa, Mayumi
|
|
2009
|
10 |
Supplement 1 |
p. 249-251
3 p.
|
article
|
| 5 |
Developing an Effective Lung Cancer Program in a Community Hospital Setting
|
Fischel, Richard J.
|
|
2009
|
10 |
Supplement 1 |
p. 239-243
5 p.
|
article
|
| 6 |
Development of the Monoclonal Antibody Figitumumab, Targeting the Insulin-like Growth Factor-1 Receptor, for the Treatment of Patients with Non–Small-Cell Lung Cancer
|
Gualberto, Antonio
|
|
2009
|
10 |
Supplement 1 |
p. 273-280
8 p.
|
article
|
| 7 |
Expression of MRP1, BCRP, LRP, and ERCC1 in Advanced Non–Small-Cell Lung Cancer: Correlation With Response to Chemotherapy and Survival
|
Li, Jian
|
|
2009
|
10 |
Supplement 1 |
p. 414-421
8 p.
|
article
|
| 8 |
Induction Chemotherapy and Chemoradiation Therapy for Inoperable Locally Advanced Non–Small-Cell Lung Cancer: A Single-Institution Review of Two Different Regimens
|
Kocak, Mihriban
|
|
2009
|
10 |
Supplement 1 |
p. 124-129
6 p.
|
article
|
| 9 |
Predictors of Long-Term Survival in Patients with Lung Cancer Included in the Randomized Spanish Lung Cancer Group 0008 Phase II Trial Using Concomitant Chemoradiation with Docetaxel and Carboplatin plus Induction or Consolidation Chemotherapy
|
Garrido, Pilar
|
|
2009
|
10 |
Supplement 1 |
p. 180-186
7 p.
|
article
|
| 10 |
PROCLAIM: A Phase III Study of Pemetrexed, Cisplatin, and Radiation Therapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiation Therapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Locally Advanced Stage III Non–Small-Cell Lung Cancer of Other than Predominantly Squamous Cell Histology
|
Vokes, Everett E.
|
|
2009
|
10 |
Supplement 1 |
p. 193-198
6 p.
|
article
|
| 11 |
S-1: A New Oral Fluoropyrimidine in the Treatment of Patients with Advanced Non–Small-Cell Lung Cancer
|
Okamoto, Isamu
|
|
2009
|
10 |
Supplement 1 |
p. 290-294
5 p.
|
article
|
| 12 |
Therapy-Related Acute Myelogenous Leukemia With an 11q23/MLL Translocation Following Adjuvant Cisplatin and Vinorelbine for Non–Small-Cell Lung Cancer
|
Faller, Bryan A.
|
|
2009
|
10 |
Supplement 1 |
p. 438-440
3 p.
|
article
|
| 13 |
The Rationale and Development of Therapeutic Insulin-like Growth Factor Axis Inhibition for Lung and Other Cancers
|
Camidge, D. Ross
|
|
2009
|
10 |
Supplement 1 |
p. 262-272
11 p.
|
article
|
| 14 |
XPG mRNA Expression Levels Modulate Prognosis in Resected Non–Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression
|
Bartolucci, Roberta
|
|
2009
|
10 |
Supplement 1 |
p. 47-52
6 p.
|
article
|
Journal description